| |
| Magyar Plasztikai Helyreállító és Esztétikai Sebész Társaság |
|
| EBOPRAS Examination |
 Rendezvény kezdete: 2007.11.09. | Rendezvény vége: 2007.11.10. |
| A rendezvény Web oldala: http://www.ebopras.eu |
Applications are being considered for the 2007 examination to be held in Madrid, Spain on 9th & 10th November.
Eligibility to sit the EBOPRAS examination
To be eligible to sit the exam, candidates must meet the following criteria regarding nationality and specialist status:
Nationality: Candidates must be citizens of an EU member state or a full or associate member country of the European Union of Medical Specialists (UEMS) (website: www.uems.net).
Specialist status: Candidates must be registered specialists in Plastic Surgery in either an EU member state or a full or associate member country of the UEMS.
Trainees: As a concession, trainees in their final year of plastic surgical training in an EU/UEMS country may sit the examination provided they have met all other requirements for eligibility for specialist status in that country (e.g. national examination). However, the diploma cannot be awarded until they have achieved specialist status in plastic surgery in that country.
Future examination venues:
• 2008 – Zagreb, Croatia
• 2009 – Aachen, Germany
Candidates are therefore advised to apply early. As at 14th March 2007, 32 candidates have applied, and 14 of them have completed the application process and been accepted. |
|
|
 |
| |
| Magyar Plasztikai Helyreállító és Esztétikai Sebész Társaság |
|
| EBOPRAS Examination |
| Rendezvény kezdete: 2007.11.09. | Rendezvény vége: 2007.11.10. |
| A rendezvény Web oldala: http://www.ebopras.eu |
Applications are being considered for the 2007 examination to be held in Madrid, Spain on 9th & 10th November.
Eligibility to sit the EBOPRAS examination
To be eligible to sit the exam, candidates must meet the following criteria regarding nationality and specialist status:
Nationality: Candidates must be citizens of an EU member state or a full or associate member country of the European Union of Medical Specialists (UEMS) (website: www.uems.net).
Specialist status: Candidates must be registered specialists in Plastic Surgery in either an EU member state or a full or associate member country of the UEMS.
Trainees: As a concession, trainees in their final year of plastic surgical training in an EU/UEMS country may sit the examination provided they have met all other requirements for eligibility for specialist status in that country (e.g. national examination). However, the diploma cannot be awarded until they have achieved specialist status in plastic surgery in that country.
Future examination venues:
• 2008 – Zagreb, Croatia
• 2009 – Aachen, Germany
Candidates are therefore advised to apply early. As at 14th March 2007, 32 candidates have applied, and 14 of them have completed the application process and been accepted. |
|
|
|
| |
| Magyar Plasztikai Helyreállító és Esztétikai Sebész Társaság |
|
| EBOPRAS Examination |
| Rendezvény kezdete: 2007.11.09. | Rendezvény vége: 2007.11.10. |
| A rendezvény Web oldala: http://www.ebopras.eu |
Applications are being considered for the 2007 examination to be held in Madrid, Spain on 9th & 10th November.
Eligibility to sit the EBOPRAS examination
To be eligible to sit the exam, candidates must meet the following criteria regarding nationality and specialist status:
Nationality: Candidates must be citizens of an EU member state or a full or associate member country of the European Union of Medical Specialists (UEMS) (website: www.uems.net).
Specialist status: Candidates must be registered specialists in Plastic Surgery in either an EU member state or a full or associate member country of the UEMS.
Trainees: As a concession, trainees in their final year of plastic surgical training in an EU/UEMS country may sit the examination provided they have met all other requirements for eligibility for specialist status in that country (e.g. national examination). However, the diploma cannot be awarded until they have achieved specialist status in plastic surgery in that country.
Future examination venues:
• 2008 – Zagreb, Croatia
• 2009 – Aachen, Germany
Candidates are therefore advised to apply early. As at 14th March 2007, 32 candidates have applied, and 14 of them have completed the application process and been accepted. |
|
|
|
| |
| Magyar Kardiológusok Társasága |
|
| 14th International Congress on Cardiovascular Pharmacotherapy |
| Rendezvény kezdete: 2007.11.28. | Rendezvény vége: 2007.12.02. |
| Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS |
| Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY |
| Tel: +90 312 440 20 21 |
| Fax: +90 212 258 60 78 |
| E-mail: iscp2007@figur.net |
| Helyszín: Törökország, Antalya, Sungate Port Royal Resort |
| A rendezvény Web oldala: http://www.iscp2007.org |
Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org |
|
|
|
